{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:28:34Z","timestamp":1765546114892,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017616","name":"Beijing Talents Fund","doi-asserted-by":"publisher","award":["2015000021469G234"],"award-info":[{"award-number":["2015000021469G234"]}],"id":[{"id":"10.13039\/501100017616","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.transproceed.2016.02.075","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T01:15:19Z","timestamp":1472260519000},"page":"2076-2079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adjuvant Chemotherapy With Gemcitabine Plus Cisplatin for Kidney Transplant Patients With Locally Advanced Transitional Cell Carcinoma"],"prefix":"10.1016","volume":"48","author":[{"given":"Z.P.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.C.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.W.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.02.075_bib1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ki.2013.458","article-title":"Malignancy-related mortality following kidney transplantation is common","volume":"85","author":"Farrugia","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2016.02.075_bib2","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1016\/j.transproceed.2011.09.069","article-title":"Association between urothelial carcinoma after kidney transplantation and aristolochic acid exposure: the potential role of aristolochic acid in HRas and TP53 gene mutations","volume":"43","author":"Xiao","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.02.075_bib3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00268-003-6954-3","article-title":"Transitional cell carcinoma in renal transplant recipients","volume":"27","author":"Kao","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.transproceed.2016.02.075_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12032-014-0032-6","article-title":"Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review","volume":"31","author":"Zhang","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.transproceed.2016.02.075_bib5","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.transproceed.2012.10.034","article-title":"Contralateral nephroureterectomy for renal transplant recipients with unilateral upper urinary tract transitional cell carcinoma: a report of 12 cases","volume":"45","author":"Hou","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.02.075_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12659\/AOT.881859","article-title":"Malignancy after renal transplantation in the new era of immunosuppression","volume":"16","author":"Watorek","year":"2011","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2016.02.075_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djp467","article-title":"Population-based-case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk","volume":"102","author":"Lai","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.transproceed.2016.02.075_bib8","first-page":"750","article-title":"Adjuvant chemotherapy correlates with improved survival after radical cystectomy in patients with pT3b (macroscopic perivesical tissue invasion) bladder cancer","volume":"6","author":"Kim","year":"2015","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.transproceed.2016.02.075_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2013.08.033","article-title":"Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.transproceed.2016.02.075_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A\u00a0systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"year":"2013","series-title":"Clinical practice guidelines in oncology: bladder cancer","key":"10.1016\/j.transproceed.2016.02.075_bib11"},{"key":"10.1016\/j.transproceed.2016.02.075_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2014.09.007","article-title":"Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"67","author":"Zargar","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.transproceed.2016.02.075_bib13","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"Von der Maase","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.transproceed.2016.02.075_bib14","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.transproceed.2013.06.008","article-title":"Feasibility of pre- and postoperative gemcitabine-plus-cisplatin systemic chemotherapy for the treatment of locally advanced urothelial carcinoma in kidney transplant patients","volume":"45","author":"Zhang","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.02.075_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/annonc\/mdr354","article-title":"Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial","volume":"23","author":"Cognetti","year":"2012","journal-title":"Ann Oncol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516301944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516301944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:49:58Z","timestamp":1762026598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516301944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0041134516301944"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.02.075","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Chemotherapy With Gemcitabine Plus Cisplatin for Kidney Transplant Patients With Locally Advanced Transitional Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.02.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}